A Phase I/IIa Open-Label, Dose Escalation and Cohort Expansion Trial of Oral TSR-011 in Patients With Advanced Solid Tumors and Lymphomas
Clinical trial NCT02048488 · COMPLETED
Trial details
- NCT number
- NCT02048488
- Sponsor
- Tesaro, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-01
- Primary completion
- 2016-09-01
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.